Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,580 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06789965Recruiting
Comparing two weight loss surgeries for severe obesity
This trial compares two different surgical techniques for people with severe obesity (BMI 40-50) to see which works better. It is for those who are good candidates for bariatric (weight loss) surgery.
Barcelona, BarcelonaAges 18–60 - NCT06790368Recruiting
Venom allergy treatment in real-life settings
This trial tests a venom immunotherapy for people allergic to bee or wasp stings. It aims to see how well the treatment works in everyday medical practice.
Alcorcón, MadridAges 14 years+ - NCT06791083RecruitingPhase 2
Envafolimab, Fruquintinib, and chemo before gastric cancer surgery
This trial tests a combination of two targeted drugs (Envafolimab and Fruquintinib) plus chemotherapy given before surgery for certain types of stomach cancer. The goal is to see if this approach can shrink the tumor and improve outcomes.
Fuzhou, FujianAges 18–75 - NCT06791148RecruitingPhase 2
Low-dose radiation plus chemo and immunotherapy for advanced stomach cancer
This trial tests a combination of low-dose radiation, chemotherapy, and an immunotherapy drug (AK112) for people with advanced stomach or gastroesophageal junction cancer that has progressed after first-line treatment. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
Nanjing, JiangsuAges 18–75 - NCT06791551Recruiting
Non-drug therapy before heart surgery to protect the brain
This study tests whether a simple, non-drug, non-surgical program before heart surgery can help protect your brain. It is for people with heart disease who are at higher risk for problems like stroke after surgery.
Beijing, Beijing MunicipalityAges 18–80 - NCT06792253RecruitingPhase 3
BEBT-908 plus rituximab for relapsed large B-cell lymphoma
This study tests a new drug, BEBT-908, combined with rituximab for people with diffuse large B-cell lymphoma that has come back or not responded to at least one prior treatment that included a CD20 antibody. The goal is to see if this new combination works better than standard care.
Beijing, Beijing MunicipalityAges 18–75 - NCT06792344RecruitingPhase 1
CD19 CAR-T for hard-to-treat systemic sclerosis
This study tests a new cell therapy called CD19 CAR-T for patients with systemic sclerosis that hasn't improved with standard treatments. The therapy aims to help reduce skin tightening and other symptoms.
Hangzhou, ZhejiangAges 5–18 - NCT06792825RecruitingPhase 2
Tafasitamab with lenalidomide and rituximab for new lymphoma
This trial tests a combination of three drugs (tafasitamab, lenalidomide, and rituximab) for people with newly diagnosed follicular or marginal zone lymphoma who have not had treatment before. The goal is to see if this combination works well and is safe.
Minneapolis, MinnesotaAges 18 years+ - NCT06792994Recruiting
CLL treatment sequence study for patients in GCLLSG trials
This observational study looks at the order of treatments given to people with chronic lymphocytic leukemia (CLL) who took part in certain first-line studies run by the German CLL Study Group. It aims to learn how different treatment sequences affect overall survival over time.
CologneAges 18–99 - NCT06793020Recruiting
Study of sepsis-related heart damage using a math model
This trial tests a new mathematical model to better diagnose and treat heart problems caused by sepsis. It includes adults with sepsis or septic shock who need strong blood pressure support.
VilniusAges 18 years+ - NCT06793137RecruitingPhase 2
Antibiotics before surgery for advanced rectal cancer
This trial tests if taking antibiotics before standard treatment can improve outcomes for people with advanced rectal cancer that requires surgery.
São Paulo, São PauloAges 18 years+ - NCT06793241RecruitingEarly Phase 1
Donor CAR-T cells for B-cell leukemia
This trial tests whether CAR-T cells made from a healthy donor can help treat B-cell acute lymphoblastic leukemia that has come back or not responded to treatment. It's for adults who cannot use their own cells for CAR-T therapy.
Hangzhou, ZhejiangAges 18 years+ - NCT06793540Recruiting
Self-posture therapy for leftover kidney stone pieces
This trial tests whether simple posture exercises you can do at home can help clear small leftover stone pieces from the lower part of your kidney after standard stone treatment. It could spare you from needing more procedures.
LyonAges 18–70 - NCT06793917RecruitingPhase 3
Immunotherapy plus chemo vs. chemo alone for advanced stomach cancer
This trial compares two types of chemotherapy with or without an immunotherapy drug (tislelizumab) for advanced stomach or gastroesophageal junction cancer. It aims to see which combination works better and has fewer side effects.
Fuzhou, FujianAges 18–70 - NCT06794073Recruiting
Combination therapy for advanced liver cancer
This trial is testing a combination of treatments for liver cancer that cannot be removed by surgery. It combines a targeted therapy pill (lenvatinib), an immunotherapy that boosts your immune system (PD-1 blocker), a procedure that destroys tumors with heat or cold (ablation), and a chemo procedure that delivers medicine directly to the liver (TACE). The goal is to see if this mix is safe and effective.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06794307Recruiting
Blood sugar in pregnant women receiving betamethasone for preterm birth
This study looks at how betamethasone, a steroid given to help babies' lungs mature, affects blood sugar levels in pregnant women without diabetes. It may help ensure safer treatment for women at risk of early labor.
Aarhus, Central Region DenmarkAges 18 years+ - NCT06794606Recruiting
Study for drug-resistant focal epilepsy
This trial looks at ways to diagnose and treat focal epilepsy that isn't controlled by medications. It includes patients with or without a visible brain lesion on imaging.
MilanAges 18 years+ - NCT06794658Recruiting
Using a smartphone app to help manage diabetes on insulin
This clinical trial tests whether using a smartphone app (called Caaring) can help people with diabetes on insulin better manage their blood sugar. If you take insulin and already monitor your blood sugar, this study may help you track your health remotely.
Valladolid, Castille and LeónAges Any age - NCT06795074RecruitingPhase 4
Comparing coated vs non-coated balloons for recurring urethral stricture
This trial tests if a balloon coated with a drug (paclitaxel) helps prevent the urethra from narrowing again after treatment. It may be an option for people whose stricture has come back after a prior procedure.
GothenburgAges 18 years+ - NCT06795932Recruiting
Testing a new nerve stimulation device for frozen shoulder
This study tests if a non-invasive device that stimulates nerves can help treat frozen shoulder (adhesive capsulitis). If you are an adult with frozen shoulder and are in generally good health, you may be able to join to see if this device works.
Saguenay, QuebecAges 18 years+ - NCT06796517Recruiting
Immunotherapy for relapsed or refractory lymphoma
This trial tests immunotherapy for people with certain types of lymphoma (diffuse large B cell, primary mediastinal, high grade, or Burkitt) that came back or didn't respond to previous treatment. It aims to see if a new immune-based approach can help.
SeoulAges 19–74 - NCT06797024Recruiting
Study of JY231 injection for tough nerve immune disorders
This trial tests a new injection called JY231 for people with certain hard-to-treat nerve and immune disorders that haven't improved with standard treatments. It aims to see if this experimental therapy can help control the disease when other options have failed.
Wuhan, HubeiAges 18–75 - NCT06797245Recruiting
App-based treatment for overactive bladder in women
This trial tests a prescription digital app to help women with overactive bladder (OAB) symptoms. It may be a good fit if you are a woman over 22 with bothersome OAB and are willing to use the app instead of other treatments for 8 weeks.
Birmingham, AlabamaAges 22 years+ - NCT06798402RecruitingPhase 2
Ciprofloxacin injections for skin sores from leishmaniasis
This study tests whether an injection of ciprofloxacin (an antibiotic) directly into skin sores can treat cutaneous leishmaniasis as effectively as the standard medicine, sodium stibogluconate. It may be an option if you have a small number of sores and have not been treated recently.
BaghdadAges 18–80
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,580 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.